BK
Bhaskar Kandagatla
About Bhaskar Kandagatla
Data last updated:
Bhaskar Kandagatla is a Director at Syngreen Lifesciences Private Limited (since 2021), Director at Chemshopy Solutions Private Limited (since 2025) and Director at Nihita Therapeutics Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma and Paper. The largest current company by reported revenue is Syngreen Lifesciences Private Limited at ₹10.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Syngreen Lifesciences Private Limited U33125TG2021PTC152936 | Director | 08 Jul 2021 | 2021 | ₹10.5 Lakh (FY 2025) | Active |
| Chemshopy Solutions Private Limited U46691TS2025PTC200093 | Director | 19 Jun 2025 | 2025 | Active | |
| Nihita Therapeutics Private Limited U21001TS2024PTC186210 | Director | 03 Jun 2024 | 2024 | Active | |
| Smagen Pharma Private Limited U21001TS2024PTC185948 | Director | 28 May 2024 | 2024 | Active |
Board colleagues of Bhaskar Kandagatla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Swaroopa Rani Kandagatla | 07203408 | Syngreen Lifesciences Private Limited | Additional Director |
| Swetha Theerupally | 09724686 | Chemshopy Solutions Private Limited | Director |
| Venkataramana Reddy Thirupalli | 09409805 | Chemshopy Solutions Private Limited | Managing Director |
| Prabhat Arya | 02899287 | Nihita Therapeutics Private Limited , Smagen Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhaskar Kandagatla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhaskar Kandagatla
Bhaskar Kandagatla currently holds 4 directorships: Syngreen Lifesciences Private Limited (Director, since 08 Jul 2021, revenue ₹10.5 Lakh (FY 2025)); Chemshopy Solutions Private Limited (Director, since 19 Jun 2025); Nihita Therapeutics Private Limited (Director, since 03 Jun 2024); Smagen Pharma Private Limited (Director, since 28 May 2024).
Bhaskar Kandagatla was first appointed on 08 Jul 2021 as Director at Syngreen Lifesciences Private Limited. The most recent appointment on record is 19 Jun 2025 at Chemshopy Solutions Private Limited.
The current boards of Bhaskar Kandagatla's companies include Swaroopa Rani Kandagatla (Syngreen Lifesciences Private Limited), Swetha Theerupally (Chemshopy Solutions Private Limited), Venkataramana Reddy Thirupalli (Chemshopy Solutions Private Limited), Prabhat Arya (Nihita Therapeutics Private Limited).